Use of intrathecal baclofen in the treatment of patients with dystonia

Archives of Neurology
B FordS Fahn

Abstract

Continuous infusion of intrathecal (IT) baclofen is a highly effective standard therapy for severe spasticity of spinal origin. By contrast, there is limited clinical experience regarding the use of IT baclofen in treating patients with dystonia, and little is known regarding the indications for treatment, efficacy, and safety of IT baclofen in this disorder. To study retrospectively the effects of IT baclofen in treating 25 patients with severe segmental or generalized dystonia. Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY. Twenty-five patients with severe segmental or generalized dystonia that was refractory to oral medications underwent IT baclofen test dosing. In addition to dystonia, 17 patients had spasticity or painful spasms. Thirteen of 25 patients responded to the test doses of IT baclofen, according to unblinded neurological assessments that included the patient's subjective report; all 13 underwent implantation of a pump for continuous IT baclofen infusion. In contrast to reports of patients with spasticity of spinal origin, those with dystonia in the present series had a lower response rate to bolus IT baclofen doses and a smaller degree of clinical improvement. For 10 of the 13 respon...Continue Reading

Citations

Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A DalviB Ford
Apr 15, 2003·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Mélanie LangloisSylvain Chouinard
Apr 9, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jill L Ostrem, Philip A Starr
Mar 9, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Bernard Dachy, Bernard Dan
May 2, 2003·Current Pain and Headache Reports·E Daniela Hord, Anne Louise Oaklander
Oct 12, 2012·CNS Drugs·Munazza Sophie, Blair Ford
Nov 30, 2000·Current Treatment Options in Neurology·S B Bressman, P E Greene
Jun 7, 2003·Current Treatment Options in Neurology·Vanessa K. Hinson, Christopher G. Goetz
Dec 25, 2013·PM & R : the Journal of Injury, Function, and Rehabilitation·Napala R Pratini, Jacob A Neufeld
Jan 17, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Salvatore GrossoPaolo Balestri
Sep 28, 2010·The Orthopedic Clinics of North America·Laura L Deon, Deborah Gaebler-Spira
Sep 8, 2010·Neurologic Clinics·Ninith Kartha
Nov 1, 2008·Journal of the Neurological Sciences·Jian-Guo ZhaoZhen-Hua Xu
Apr 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo MariottiAnna Rita Bentivoglio
Mar 27, 2012·Neuromodulation : Journal of the International Neuromodulation Society·Elliot S Krames
Oct 6, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Travis S Tierney, Andres M Lozano
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Blair Ford
Jan 27, 1998·The Psychiatric Clinics of North America·F Cardoso, J Jankovic
Jan 23, 1999·Archives of Physical Medicine and Rehabilitation·J M MeythalerM N Hadley
Dec 23, 2011·Parkinsonism & Related Disorders·Francesca Del Sorbo, Alberto Albanese
Apr 2, 2013·Journal of Pain and Symptom Management·Jillian F RorkRichard D Goldstein
Jun 2, 2001·Archives of Physical Medicine and Rehabilitation·M S Jaffe, L J Nienstedt
Mar 18, 2008·Oral and Maxillofacial Surgery Clinics of North America·Ramesh Balasubramaniam, Saravanan Ram
Dec 23, 2006·Dental Clinics of North America·Glenn T Clark, Saravanan Ram
Jan 6, 2009·Journal of Neurosurgery. Pediatrics·A Leland Albright, Susan S Ferson
Aug 22, 2006·Neurosurgical Focus·Joseph C Hsieh, Richard D Penn
Mar 4, 2000·Journal of Neurosurgery·V M Tronnier, W Fogel
Jun 3, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y Balash, N Giladi
Jul 27, 2001·Neurologic Clinics·C G Goetz, S S Horn
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R H WalkerM F Brin
May 21, 2004·Journal of Paediatrics and Child Health·M KyriagisM Waugh
Dec 17, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·N J DiederichH Metz
Sep 8, 2001·Stroke; a Journal of Cerebral Circulation·J M MeythalerM N Hadley
Jun 7, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Ron L Alterman, Michele Tagliati
Jul 13, 2004·The Journal of Head Trauma Rehabilitation·Jay M MeythalerRobert C Brunner
Jun 21, 2006·Expert Review of Neurotherapeutics·Roongroj Bhidayasiri, Daniel Tarsy
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Joaquim J FerreiraCristina Sampaio
Aug 7, 2007·British Journal of Neurosurgery·K WoonM H Vloeberghs
Jul 24, 2008·British Journal of Neurosurgery·P M Brennan, I R Whittle
Apr 3, 2003·Clinical Neuropharmacology·Jennifer G Goldman, Cynthia L Comella

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved